BioSpace News Archive

Biotech Beach

BioCorRx Attended 4th Annual NIH HEAL Initiative Investigator Meeting; Shares Update on BICX104 Data

BioCorRx Inc. announced today that Dr. Andrew Mallon, CSO and Grant Principal Investigator on the Phase I clinical trial of BICX104, an implantable biodegradable naltrexone pellet for the treatment of opioid use disorder (OUD), attended and presented a poster on BICX104.

February 23, 2023

·

4 min read

BioMidwest

Theralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone

Theralink Technologies, a precision oncology company with a novel phosphoprotein-based assay for advanced breast cancer, announced that the Company has begun receiving payments from third party payors for its advanced breast cancer assay.

February 23, 2023

·

3 min read

Biotech Beach

Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, announced preliminary results from preclinical testing of its PGN-OB2 program, reporting an average bioavailability of 37% for semaglutide, a GLP-1 receptor agonist.

February 23, 2023

·

7 min read

Biotech Beach

Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China

The College of American Pathologists is a professional organization that accredits clinical laboratories across the world. The CAP accreditation process is designed to ensure that laboratories meet or exceed the highest quality management system standards specific to patient testing.

February 23, 2023

·

5 min read

Business

Clario Teams with WeWork to Enhance Hybrid Work Strategy; Flexible Workspace to be Accessible for Thousands of Employees Worldwide

Clario and WeWork have partnered to provide Clario’s workforce with WeWork All Access passes and flexible space across the United States, United Kingdom, Germany, Belgium, Hungary, and Costa Rica, giving colleagues even more flexibility with where they work.

February 23, 2023

·

4 min read

Biotech Bay

Memora Health Announces Partnership with Moffitt Cancer Center to Scale Data-Driven Cancer Care

Memora Health, the leading intelligent platform for virtual care delivery and complex care management, announced a partnership with Moffitt Cancer Center, one of the nation’s leading cancer care and research institutions.

February 23, 2023

·

3 min read

Business

Nanox to Report Fourth Quarter 2022 Financial Results on March 9, 2023

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX) will report its financial results for the fourth quarter ended December 31, 2022 before market on Thursday, March 9, 2023.

February 23, 2023

·

4 min read

Drug Development

Skye Bioscience Receives Positive Safety Review of SBI-100 Ophthalmic Emulsion After Second Cohort of Phase 1 Study

Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma,

February 23, 2023

·

3 min read

Pharm Country

The Mark Foundation for Cancer Research Accelerates Global Commitment to Innovation with 12 New ASPIRE Awards Totaling Over $4 Million

The Mark Foundation for Cancer Research announced twelve outstanding research projects to receive its latest round of ASPIRE awards.

February 23, 2023

·

4 min read

Genetown

The Latest Discoveries in Rheumatology Research at the Arthritis National Research Foundation 2023 Research Scholar Symposium

The Arthritis National Research Foundation (ANRF) 2023 Research Scholar Symposium on March 11th, 8 AM - 5 PM at the Hyatt Regency Boston, offers attendees exposure to cutting-edge research they cannot find anywhere else.

February 23, 2023

·

2 min read